1. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. (April 2022) Authors: Cohen, Jeffrey A; Cameron, Michelle H; Goldman, Myla D; Goodman, Andrew D; Miller, Aaron E; Rollins, Anne; Llorens, Lily; Patni, Rajiv; Elfont, Robert; Johnson, Reed Journal: Multiple sclerosis Issue: Volume 28:Number 5(2022) Page Start: 817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study. Issue 2 (May 2018) Authors: Cleanthous, Sophie; Strzok, Sara; Pompilus, Farrah; Cano, Stefan; Marquis, Patrick; Cohan, Stanley; Goldman, Myla D; Kresa-Reahl, Kiren; Petrillo, Jennifer; Castrillo-Viguera, Carmen; Cadavid, Diego; Chen, Shih-Yin Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safety. (October 2014) Authors: Jones, David E; Goldman, Myla D Journal: Expert review of clinical immunology Issue: Volume 10:Number 10(2014) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safety. (October 2014) Authors: Jones, David E; Goldman, Myla D Journal: Expert review of clinical immunology Issue: Volume 10:Number 10(2014) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Body mass index trajectories in pediatric multiple sclerosis. (5th April 2019) Authors: Brenton, J Nicholas; Woolbright, Emma; Briscoe‐Abath, Christina; Qureshi, Asma; Conaway, Mark; Goldman, Myla D Journal: Developmental medicine & child neurology Issue: Volume 61:Number 11(2019) Page Start: 1289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study. Issue 2 (June 2018) Authors: Strzok, Sara; Cleanthous, Sophie; Pompilus, Farrah; Cano, Stefan J; Marquis, Patrick; Cohan, Stanley; Goldman, Myla D; Kresa-Reahl, Kiren; Petrillo, Jennifer; Castrillo-Viguera, Carmen; Cadavid, Diego; Chen, Shih-Yin Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. Issue 5 (May 2018) Authors: Kapoor, Raju; Ho, Pei-Ran; Campbell, Nolan; Chang, Ih; Deykin, Aaron; Forrestal, Fiona; Lucas, Nisha; Yu, Bei; Arnold, Douglas L; Freedman, Mark S; Goldman, Myla D; Hartung, Hans-Peter; Havrdová, Eva Kubala; Jeffery, Douglas; Miller, Aaron; Sellebjerg, Finn; Cadavid, Diego; Mikol, Dan; Steiner, D... Journal: Lancet neurology Issue: Volume 17:Issue 5(2018) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fatigue and fluid hydration status in multiple sclerosis: A hypothesis. (October 2016) Authors: Cincotta, Molly C; Engelhard, Matthew M; Stankey, Makela; Goldman, Myla D Journal: Multiple sclerosis Issue: Volume 22:Number 11(2016) Page Start: 1438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale. (September 2017) Authors: Goldman, Myla D; Ward, Melanie D; Motl, Robert W; Jones, David E; Pula, John H; Cadavid, Diego Journal: Multiple sclerosis Issue: Volume 23:Number 10(2017) Page Start: 1405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis. (July 2014) Authors: Ward, Melanie D; Jones, David E; Goldman, Myla D Journal: Expert opinion on drug safety Issue: Volume 13:Number 7(2014) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗